{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:50:11Z","timestamp":1784224211887,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T00:00:00Z","timestamp":1418688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s40262-014-0226-2","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T08:49:24Z","timestamp":1418633364000},"page":"627-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Effects of Alcohol on Human Carboxylesterase Drug Metabolism"],"prefix":"10.1007","volume":"54","author":[{"given":"Robert B.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Yi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Meibohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Casey","family":"Laizure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"issue":"9\u201310","key":"226_CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00335-010-9284-4","volume":"21","author":"RS Holmes","year":"2010","unstructured":"Holmes RS, Wright MW, Laulederkind SJ, Cox LA, Hosokawa M, Imai T, et al. Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins. Mamm Genome. 2010;21(9\u201310):427\u201341.","journal-title":"Mamm Genome"},{"issue":"3","key":"226_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cbi.2006.07.001","volume":"162","author":"T Satoh","year":"2006","unstructured":"Satoh T, Hosokawa M. Structure, function and regulation of carboxylesterases. Chem Biol Interact. 2006;162(3):195\u2013211.","journal-title":"Chem Biol Interact"},{"issue":"5","key":"226_CR3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/dmd.30.5.488","volume":"30","author":"T Satoh","year":"2002","unstructured":"Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, La Du BN. Current progress on esterases: from molecular structure to function. Drug Metab Dispos. 2002;30(5):488\u201393.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"226_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","volume":"33","author":"SC Laizure","year":"2013","unstructured":"Laizure SC, Herring VL, Hu Z, Witbrodt K, Parker RB. The role of human carboxylesterases in drug metabolism: have we overlooked their importance? Pharmacotherapy. 2013;33(2):210\u201322.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"226_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.113.054353","volume":"42","author":"SC Laizure","year":"2014","unstructured":"Laizure SC, Parker RB, Herring VL, Hu ZY. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis. Drug Metab Dispos. 2014;42(2):201\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"226_CR6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","volume":"13","author":"M Hosokawa","year":"2008","unstructured":"Hosokawa M. Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs. Molecules. 2008;13(2):412\u201331.","journal-title":"Molecules"},{"issue":"10","key":"226_CR7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.106.009381","volume":"34","author":"T Imai","year":"2006","unstructured":"Imai T, Taketani M, Shii M, Hosokawa M, Chiba K. Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos. 2006;34(10):1734\u201341.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"226_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0091270004265367","volume":"44","author":"SM Huang","year":"2004","unstructured":"Huang SM, Lesko LJ. Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J Clin Pharmacol. 2004;44(6):559\u201369.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"226_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.clpt.6100054","volume":"81","author":"SM Huang","year":"2007","unstructured":"Huang SM, Temple R, Throckmorton DC, Lesko LJ. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther. 2007;81(2):298\u2013304.","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"226_CR10","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1096\/fasebj.5.12.1916095","volume":"5","author":"RA Dean","year":"1991","unstructured":"Dean RA, Christian CD, Sample RH, Bosron WF. Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine. FASEB J. 1991;5(12):2735\u20139.","journal-title":"FASEB J"},{"issue":"2","key":"226_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/dmd.109.030056","volume":"38","author":"RB Parker","year":"2010","unstructured":"Parker RB, Laizure SC. The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions. Drug Metab Dispos. 2010;38(2):317\u201322.","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"226_CR12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0090-9556(25)07443-4","volume":"24","author":"RB Parker","year":"1996","unstructured":"Parker RB, Williams CL, Laizure SC, Mandrell TD, LaBranche GS, Lima JJ. Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs. Drug Metab Dispos. 1996;24(8):850\u20133.","journal-title":"Drug Metab Dispos"},{"issue":"23","key":"226_CR13","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0024-3205(99)00159-9","volume":"64","author":"N Song","year":"1999","unstructured":"Song N, Parker RB, Laizure SC. Cocaethylene formation in rat, dog, and human hepatic microsomes. Life Sci. 1999;64(23):2101\u20138.","journal-title":"Life Sci"},{"key":"226_CR14","first-page":"437","volume":"14","author":"J Cami","year":"1998","unstructured":"Cami J, Farre M, Gonzalez ML, Segura J, de la Torre R. Cocaine metabolism in humans after use of alcohol. Clin Res Implic Recent Dev Alcohol. 1998;14:437\u201355.","journal-title":"Clin Res Implic Recent Dev Alcohol"},{"issue":"1","key":"226_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)36982-4","volume":"283","author":"M Farre","year":"1997","unstructured":"Farre M, de la Torre R, Gonzalez ML, Teran MT, Roset PN, Menoyo E, et al. Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. J Pharmacol Exp Ther. 1997;283(1):164\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"226_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1037\/a0022950","volume":"19","author":"ED Herbst","year":"2011","unstructured":"Herbst ED, Harris DS, Everhart ET, Mendelson J, Jacob P, Jones RT. Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol. 2011;19(2):95\u2013104.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"226_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02257405","volume":"111","author":"EF McCance-Katz","year":"1993","unstructured":"McCance-Katz EF, Price LH, McDougle CJ, Kosten TR, Black JE, Jatlow PI. Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl). 1993;111(1):39\u201346.","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"226_CR18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3565(25)12151-4","volume":"275","author":"RA Dean","year":"1995","unstructured":"Dean RA, Zhang J, Brzezinski MR, Bosron WF. Tissue distribution of cocaine methyl esterase and ethyl transferase activities: correlation with carboxylesterase protein. J Pharmacol Exp Ther. 1995;275(2):965\u201371.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"226_CR19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","volume":"279","author":"LM Kamendulis","year":"1996","unstructured":"Kamendulis LM, Brzezinski MR, Pindel EV, Bosron WF, Dean RA. Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J Pharmacol Exp Ther. 1996;279(2):713\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"226_CR20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-9556(24)15139-2","volume":"28","author":"JS Markowitz","year":"2000","unstructured":"Markowitz JS, DeVane CL, Boulton DW, Nahas Z, Risch SC, Diamond F, et al. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. Drug Metab Dispos. 2000;28(6):620\u20134.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"226_CR21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/sj.clpt.6100082","volume":"81","author":"KS Patrick","year":"2007","unstructured":"Patrick KS, Straughn AB, Minhinnett RR, Yeatts SD, Herrin AE, DeVane CL, et al. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2007;81(3):346\u201353.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"226_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/dmd.112.048595","volume":"41","author":"KS Patrick","year":"2013","unstructured":"Patrick KS, Straughn AB, Reeves OT 3rd, Bernstein H, Bell GH, Anderson ER, et al. Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans. Drug Metab Dispos. 2013;41(1):197\u2013205.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"226_CR23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/dmd.108.024331","volume":"37","author":"S Takahashi","year":"2009","unstructured":"Takahashi S, Katoh M, Saitoh T, Nakajima M, Yokoi T. Different inhibitory effects in rat and human carboxylesterases. Drug Metab Dispos. 2009;37(5):956\u201361.","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"226_CR24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.lfs.2007.07.026","volume":"81","author":"M Taketani","year":"2007","unstructured":"Taketani M, Shii M, Ohura K, Ninomiya S, Imai T. Carboxylesterase in the liver and small intestine of experimental animals and human. Life Sci. 2007;81(11):924\u201332.","journal-title":"Life Sci"},{"key":"226_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpba.2012.08.029","volume":"72","author":"ZY Hu","year":"2013","unstructured":"Hu ZY, Laizure SC, Meibohm B, Herring VL, Parker RB. Simple and sensitive assay for quantification of oseltamivir and its active metabolite oseltamivir carboxylate in human plasma using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry: improved applicability to pharmacokinetic study. J Pharm Biomed Anal. 2013;72:245\u201350.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"226_CR26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/0021-843X.112.3.424","volume":"112","author":"JJ Curtin","year":"2003","unstructured":"Curtin JJ, Fairchild BA. Alcohol and cognitive control: implications for regulation of behavior during response conflict. J Abnorm Psychol. 2003;112(3):424\u201336.","journal-title":"J Abnorm Psychol"},{"issue":"5","key":"226_CR27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1073\/pnas.84.5.1417","volume":"84","author":"GA Higgs","year":"1987","unstructured":"Higgs GA, Salmon JA, Henderson B, Vane JR. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA. 1987;84(5):1417\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"226_CR28","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/AAC.00500-06","volume":"50","author":"N Lindegardh","year":"2006","unstructured":"Lindegardh N, Davies GR, Tran TH, Farrar J, Singhasivanon P, Day NP, et al. Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases. Antimicrob Agents Chemother. 2006;50(9):3197\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"226_CR29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","volume":"37","author":"G He","year":"1999","unstructured":"He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet. 1999;37(6):471\u201384.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"226_CR30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jep.2012.07.029","volume":"143","author":"L Zhou","year":"2012","unstructured":"Zhou L, Wang S, Zhang Z, Lau BS, Fung KP, Leung PC, et al. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin. J Ethnopharmacol. 2012;143(2):648\u201355.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"226_CR31","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","volume":"319","author":"D Shi","year":"2006","unstructured":"Shi D, Yang J, Yang D, LeCluyse EL, Black C, You L, et al. Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther. 2006;319(3):1477\u201384.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"226_CR32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/dmd.107.020248","volume":"36","author":"ET Williams","year":"2008","unstructured":"Williams ET, Jones KO, Ponsler GD, Lowery SM, Perkins EJ, Wrighton SA, et al. The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2. Drug Metab Dispos. 2008;36(7):1227\u201332.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"226_CR33","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bcp.2008.12.017","volume":"77","author":"HJ Zhu","year":"2009","unstructured":"Zhu HJ, Appel DI, Johnson JA, Chavin KD, Markowitz JS. Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril. Biochem Pharmacol. 2009;77(7):1266\u201372.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"226_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2007.08.054","volume":"426","author":"Y Izumi","year":"2007","unstructured":"Izumi Y, Tokuda K, O\u2019Dell KA, Zorumski CF, Narahashi T. Neuroexcitatory actions of Tamiflu and its carboxylate metabolite. Neurosci Lett. 2007;426(1):54\u20138.","journal-title":"Neurosci Lett"},{"issue":"12","key":"226_CR35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/BF03262007","volume":"35","author":"M Jones","year":"2012","unstructured":"Jones M, Hama R, Jefferson T, Doshi P. Neuropsychiatric adverse events and oseltamivir for prophylaxis. Drug Saf. 2012;35(12):1187\u20138 author reply 8-90.","journal-title":"Drug Saf"},{"issue":"1","key":"226_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-008X(92)90210-J","volume":"117","author":"RA Dean","year":"1992","unstructured":"Dean RA, Harper ET, Dumaual N, Stoeckel DA, Bosron WF. Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol Appl Pharmacol. 1992;117(1):1\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"226_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/dmd.31.1.16","volume":"31","author":"SC Laizure","year":"2003","unstructured":"Laizure SC, Mandrell T, Gades NM, Parker RB. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases. Drug Metab Dispos. 2003;31(1):16\u201320.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"226_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-9556(25)07412-4","volume":"21","author":"SM Roberts","year":"1993","unstructured":"Roberts SM, Harbison RD, James RC. Inhibition by ethanol of the metabolism of cocaine to benzoylecgonine and ecgonine methyl ester in mouse and human liver. Drug Metab Dispos. 1993;21(3):537\u201341.","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"226_CR39","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/0006-2952(94)90461-8","volume":"48","author":"MR Brzezinski","year":"1994","unstructured":"Brzezinski MR, Abraham TL, Stone CL, Dean RA, Bosron WF. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. Biochem Pharmacol. 1994;48(9):1747\u201355.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"226_CR40","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.00588-08","volume":"53","author":"Y Wattanagoon","year":"2009","unstructured":"Wattanagoon Y, Stepniewska K, Lindegardh N, Pukrittayakamee S, Silachamroon U, Piyaphanee W, et al. Pharmacokinetics of high-dose oseltamivir in healthy volunteers. Antimicrob Agents Chemother. 2009;53(3):945\u201352.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"226_CR41","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/AAC.00200-12","volume":"56","author":"BJ Brennan","year":"2012","unstructured":"Brennan BJ, Davies B, Cirrincione-Dall G, Morcos PN, Beryozkina A, Chappey C, et al. Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers. Antimicrob Agents Chemother. 2012;56(9):4729\u201337.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"226_CR42","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/rcm.6901","volume":"28","author":"ZY Hu","year":"2014","unstructured":"Hu ZY, Laizure SC, Herring VL, Parker RB. Identification of alcohol-dependent clopidogrel metabolites using conventional liquid chromatography\/triple quadrupole mass spectrometry. Rapid Commun Mass Spectrom. 2014;28(11):1285\u201392.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"3","key":"226_CR43","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1124\/jpet.106.110577","volume":"319","author":"M Tang","year":"2006","unstructured":"Tang M, Mukundan M, Yang J, Charpentier N, LeCluyse EL, Black C, et al. Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol. J Pharmacol Exp Ther. 2006;319(3):1467\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"226_CR44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(03)00200-X","volume":"72","author":"DS Harris","year":"2003","unstructured":"Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003;72(2):169\u201382.","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"226_CR45","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1021\/jm0490989","volume":"48","author":"KS Patrick","year":"2005","unstructured":"Patrick KS, Williard RL, VanWert AL, Dowd JJ, Oatis JE Jr, Middaugh LD. Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol. J Med Chem. 2005;48(8):2876\u201381.","journal-title":"J Med Chem"},{"issue":"3","key":"226_CR46","first-page":"203","volume":"26","author":"JA Bourland","year":"1998","unstructured":"Bourland JA, Martin DK, Mayersohn M. In vitro transesterification of cocaethylene (ethylcocaine) in the presence of ethanol esterase-mediated ethyl ester exchange. Drug Metab Dispos. 1998;26(3):203\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"226_CR47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/dmd.113.054049","volume":"42","author":"H Chanteux","year":"2014","unstructured":"Chanteux H, Rosa M, Delatour C, Prakash C, Smith S, Nicolas JM. In vitro hydrolysis and transesterification of CDP323, an alpha4beta1\/alpha4beta7 integrin antagonist ester prodrug. Drug Metab Dispos. 2014;42(1):153\u201361.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"226_CR48","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1124\/dmd.113.051805","volume":"41","author":"FG Bahar","year":"2013","unstructured":"Bahar FG, Imai T. Aspirin hydrolysis in human and experimental animal plasma and the effect of metal cations on hydrolase activities. Drug Metab Dispos. 2013;41(7):1450\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"226_CR49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jps.2600610312","volume":"61","author":"M Rowland","year":"1972","unstructured":"Rowland M, Riegelman S, Harris PA, Sholkoff SD. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci. 1972;61(3):379\u201385.","journal-title":"J Pharm Sci"},{"issue":"6","key":"226_CR50","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1213\/00000539-196511000-00034","volume":"44","author":"G Levy","year":"1965","unstructured":"Levy G. Aspirin, absorption rate and analgesic effect. Anesth Analg. 1965;44(6):837\u201341.","journal-title":"Anesth Analg"},{"issue":"17","key":"226_CR51","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1074\/jbc.M112.427674","volume":"288","author":"G Zhou","year":"2013","unstructured":"Zhou G, Marathe GK, Hartiala J, Hazen SL, Allayee H, Tang WH, et al. Aspirin hydrolysis in plasma is a variable function of butyrylcholinesterase and platelet-activating factor acetylhydrolase 1b2 (PAFAH1b2). J Biol Chem. 2013;288(17):11940\u20138.","journal-title":"J Biol Chem"},{"issue":"12","key":"226_CR52","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1111\/j.1572-0241.2000.03347.x","volume":"95","author":"L Bujanda","year":"2000","unstructured":"Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000;95(12):3374\u201382.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"226_CR53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","volume":"344","author":"HJ Zhu","year":"2013","unstructured":"Zhu HJ, Wang X, Gawronski BE, Brinda BJ, Angiolillo DJ, Markowitz JS. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther. 2013;344(3):665\u201372.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"226_CR54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/dmd.108.024943","volume":"37","author":"HJ Zhu","year":"2009","unstructured":"Zhu HJ, Markowitz JS. Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants. Drug Metab Dispos. 2009;37(2):264\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"226_CR55","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","volume":"82","author":"HJ Zhu","year":"2008","unstructured":"Zhu HJ, Patrick KS, Yuan HJ, Wang JS, Donovan JL, DeVane CL, et al. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet. 2008;82(6):1241\u20138.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"226_CR56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/clpt.2012.13","volume":"92","author":"EK Tarkiainen","year":"2012","unstructured":"Tarkiainen EK, Backman JT, Neuvonen M, Neuvonen PJ, Schwab M, Niemi M. Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans. Clin Pharmacol Ther. 2012;92(1):68\u201371.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0226-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-014-0226-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0226-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:53:03Z","timestamp":1747187583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-014-0226-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,16]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s40262-014-0226-2","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,16]]}}}